a month ago
BCRX
AnalystsAndrew S. FeinAndrew S. Fein's Stock Forecasts
AnalystsAndrew S. Fein
Sectors:
Analyst Ranking
Top 12%
#573 out of 5179 analysts
Average Return
+20.94%
Win Rate
60%24 out of 40
Risk vs Reward
Poor
Good
Andrew S. Fein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Day One Biopharmaceuticals IncDAWN | +108.10% | $5.80 | $12.07 | 2025-08-05 - 2026-01-21 | Buy |
Savara IncSVRA | +103.62% | $3.04 | $6.19 | 2025-08-14 - 2026-01-21 | Buy |
Arvinas IncARVN | +101.92% | $6.24 | $12.60 | 2025-08-06 - 2026-01-21 | Buy |
Palvella Therapeutics IncPVLA | +98.56% | $47.30 | $93.92 | 2025-08-14 - 2026-01-21 | Buy |
Savara IncSVRA | +80.99% | $3.42 | $6.19 | 2025-09-02 - 2026-01-21 | Buy |
Andrew S. Fein Analyst Color
Get additional color on Andrew S. Fein's coverage of popular stocks
Andrew S. Fein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Metavia IncMTVA | 2 | Buy | $40.00 | +1,288.89% | Maintains | 17 days ago |
Savara IncSVRA | 3 | Buy | $10.00 | +61.55% | Maintains | a month ago |
Wave Life Sciences LtdWVE | 2 | Buy | $30.00 | +115.21% | Maintains | a month ago |
Insmed IncINSM | 2 | Buy | $230.00 | +47.13% | Maintains | a month ago |
Dbv Technologies SaDBVT | 3 | Buy | $40.00 | +84.59% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 1 | Buy | $198.00 | +46.22% | Maintains | a month ago |
Palvella Therapeutics IncPVLA | 4 | Buy | $200.00 | +112.95% | Maintains | a month ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Buy | $32.00 | +376.19% | Maintains | a month ago |
Kymera Therapeutics IncKYMR | 3 | Buy | $134.00 | +89.43% | Maintains | a month ago |
Kamada LtdKMDA | 1 | Buy | $13.00 | +66.88% | Maintains | a month ago |
Fulcrum Therapeutics IncFULC | 3 | Buy | $25.00 | +139.92% | Maintains | a month ago |
Madrigal Pharmaceuticals IncMDGL | 3 | Buy | $620.00 | +24.76% | Maintains | 2 months ago |
Arcturus Therapeutics Holdings IncARCT | 3 | Hold | $9.00 | +23.80% | Maintains | 2 months ago |
Prothena Corp Public Ltd CoPRTA | 3 | Buy | $30.00 | +209.92% | Maintains | 2 months ago |
Liquidia CorpLQDA | 2 | Buy | $50.00 | +25.05% | Maintains | 3 months ago |
United Therapeutics CorpUTHR | 1 | Buy | $525.00 | +11.76% | Maintains | 3 months ago |
Akero Therapeutics IncAKRO | 2 | Hold | $54.00 | -1.19% | Downgrades | 3 months ago |
89bio IncETNB | 2 | Hold | $14.50 | -2.29% | Downgrades | 4 months ago |
Terns Pharmaceuticals IncTERN | 1 | Hold | $7.44 | -79.71% | Assumes | 5 months ago |
Arvinas IncARVN | 1 | Buy | $18.00 | +42.86% | Maintains | 6 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Buy | $25.00 | +107.13% | Maintains | 6 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Buy | $478.00 | +3.66% | Maintains | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.